Keyphrases
Evidence-based
100%
New Medicines
100%
Scientific Advice
100%
Marketing Authorization
100%
Clinical Outcomes
66%
Clinical Significance
50%
Odds Ratio
50%
Confidence Interval
50%
Orphan Medicinal Product
50%
Dutch
33%
Phase II Trial
33%
Approval Rate
33%
Marketing Approval
33%
Clinically Significant
16%
Medicinal Products
16%
Regulatory Agencies
16%
Risk-benefit
16%
Interview Study
16%
Regulatory System
16%
Knowledge Gaps
16%
Treatment Options
16%
Mode of Action
16%
Safety Profile
16%
Drug Development
16%
Clinical Efficacy
16%
Small to Medium Size Enterprises
16%
High Standards
16%
Medical Needs
16%
Large Firms
16%
European Medicines Agency
16%
Continuous Development
16%
Preclinical Development
16%
Non-orphans
16%
Clinical Safety
16%
New Active Substance
16%
Reassurance
16%
Authorization System
16%
Evaluation Board
16%
Product Developers
16%
Clinical Development Plan
16%
Small Companies
16%
Pharmaceutical Innovation
16%
Medicine Evaluation
16%
Efficacy Outcomes
16%
Safety Outcomes
16%
Safety-related
16%
Early Drug Development
16%
Appropriate Development
16%
Orphan Regulation
16%
Committee for Medicinal Products for Human Use
16%
Pharmacology, Toxicology and Pharmaceutical Science
Drug Development
100%
Diseases
33%